Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

inflammation · Mechanism Report

Does high-sensitivity C-reactive protein reflect systemic inflammation without identifying its source?

High-sensitivity C-reactive protein reflects systemic inflammatory signaling but cannot identify the cause or location of inflammation.

PlausibleSeptember 30, 202610 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

High-sensitivity C-reactive protein reflects systemic inflammatory signaling, although it does not identify the source of inflammation.

laying out figure…
1 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says hs-CRP is a downstream marker of the body’s acute-phase inflammatory response. The mechanism described is inflammatory signaling driving hepatic CRP production, which raises circulating hs-CRP. Because this response is nonspecific, an elevated result can signal inflammation without showing where it originates.

Verified conclusion

High-sensitivity C-reactive protein (hs-CRP) is best understood as a sensitive blood marker of the body’s acute-phase inflammatory response, not as a test that diagnoses or localizes an inflammatory disease. This interpretation applies directly to a 64-year-old woman, particularly when hs-CRP is being considered for cardiovascular-risk refinement.

Clinical evidence

  • The claim is strongly supported. In the Lothian Birth Cohort 1936, hs-CRP showed moderate correlations with interleukin-6 (IL-6) at age 73 (r=0.43, P<0.001), with repeated-measure correlations of r=0.41–0.45. Thus, hs-CRP tracks systemic inflammatory activity, but is not a direct measure of one cytokine or disease.
  • In cardiovascular prevention, hs-CRP ≥2 mg/L is an ACC/AHA risk-enhancing factor. It informs risk discussions rather than establishing cardiovascular disease or its cause.

Mechanistic basis

  • Inflammatory signaling—principally IL-6, with contributions from IL-1β and TNF-α—stimulates hepatocytes to synthesize CRP. Circulating CRP rises within hours of inflammatory stimulation.
  • High-sensitivity assays measure the same circulating CRP at low concentrations; “high sensitivity” improves low-range detection, not etiologic specificity.

Interpretation and practical considerations

  • An elevated result can arise from infection, trauma or tissue injury, autoimmune/inflammatory disease, malignancy, obesity, smoking, and other acute-phase states. It therefore cannot identify the inflammatory trigger or anatomical site.
  • Acute illness can substantially confound cardiovascular-risk interpretation. Values >10 mg/L should generally be repeated after clinical recovery or stability. Persistence on repeat testing supports an ongoing signal but still does not establish its source.

Bottom line

  • hs-CRP reliably reflects downstream systemic inflammatory signaling, but it is intrinsically nonspecific: it cannot independently determine why inflammation is present or where it originates.

References

  1. C-reactive protein in cardiovascular disease: clinical ... — frontiersin.org ↗
  2. C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results ... — pmc.ncbi.nlm.nih.gov ↗
  3. Associations between Dietary Inflammatory Index Scores and Inflammatory Biomarkers among Older Adults in the Lothian Birth Cohort 1936 Study — link.springer.com ↗
  4. Trajectories of inflammatory biomarkers over the eighth decade and their associations with immune cell profiles and epigenetic ageing — ncbi.nlm.nih.gov ↗
  5. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease | Circulation — ahajournals.org ↗
  6. High-sensitivity C-reactive Protein in Atherosclerotic ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  7. C-reactive protein: a critical update - PMC — pmc.ncbi.nlm.nih.gov ↗
  8. Interpretation of C‐Reactive Protein Concentrations in ... — onlinelibrary.wiley.com ↗
  9. Dissociation of C-Reactive Protein Localizes and Amplifies ... — pmc.ncbi.nlm.nih.gov ↗
  10. CRP (C-Reactive Protein) Revisited: An Old Yet New Biomarker ... — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Supported11 sourcesDoes elevated hs-CRP reflect systemic inflammation and cardiovascular risk without localizing the source?→Supported8 sourcesDoes elevated hs-CRP indicate systemic inflammation without identifying the source?→